Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Affinity and Avidity01:41

Affinity and Avidity

36.0K
Overview
36.0K
Antibody Actions01:26

Antibody Actions

1.1K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.1K
Hybridoma Technology01:31

Hybridoma Technology

14.7K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.7K
Cross-reactivity00:42

Cross-reactivity

31.0K
Overview
31.0K
Antibody Structure01:10

Antibody Structure

60.1K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
60.1K
Affinity Chromatography01:03

Affinity Chromatography

620
Affinity chromatography is a powerful technique extensively utilized for separating and purifying specific biomolecules from complex mixtures. It capitalizes on the highly selective binding between an analyte and its counterpart, such as antibody-antigen interactions. The counterpart is immobilized on the stationary phase, forming an affinity column. The stationary phase typically consists of solid support, such as agarose or porous glass beads, immobilizing the affinity ligand. The mobile...
620

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Association of SIRT1 rs12778366 (T > C) polymorphism with reduced esophageal cancer risk: a case-control study from North India".

Molecular biology reports·2026
Same author

Cytokine Gene Polymorphisms in Primary Glaucoma: Insights into Inflammatory Pathways and Future Directions.

Molecular neurobiology·2026
Same author

Diagnostic accuracy of rapid on-site evaluation (ROSE) during robotic bronchoscopy.

Journal of thoracic disease·2026
Same author

Complete vs Incomplete Percutaneous Oblique Distal Closing Wedge Osteotomy for Bunionette (Tailor's Bunion) Deformity Correction: A Retrospective Comparative Study.

Foot & ankle orthopaedics·2026
Same author

Unlocking the power of antimicrobial peptides to combat infectious agents.

Advances in protein chemistry and structural biology·2026
Same author

Altered MDC1 Interactions and Dysfunctional DNA Repair in Lobular Breast Cancer Confers Sensitivity to PARP Inhibition.

Cancer research·2026

相关实验视频

Updated: Jun 26, 2025

Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms
15:27

Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms

Published on: April 17, 2017

20.8K

工程高亲和抗原结合剂:超越传统抗体.

Rajeev Kumar Pandey1, Sanjana Mehrotra2

  • 1Research and Development-Protein Biology, Thermo Fisher Scientific, Bangalore, India.

Advances in protein chemistry and structural biology
|May 18, 2024
PubMed
概括

传统的抗体是多功能性的,但也有局限性. 通过蛋白质工程开发的替代抗原结合剂为诊断和治疗提供了新的解决方案.

科学领域:

  • 生物技术是生物技术.
  • 蛋白质工程是指蛋白质工程.
  • 分子诊断学 分子诊断

背景情况:

  • 抗体是建立的结合蛋白质,具有高度亲和力和特异性.
  • 传统的抗体广泛用于研究,诊断和生物技术.
  • 限制包括动物免疫,哺乳动物表达,稳定性问题和高生产成本.

研究的目的:

  • 探索超越传统抗体的替代抗原结合剂的演变.
  • 突出蛋白质工程和新型结合剂选平台的进步.
  • 讨论非传统结合剂在诊断和治疗中的扩大应用.

主要方法:

  • 对蛋白质工程方法的审查.
  • 对高通量选平台的分析.
  • 对抗体衍生和非抗体基分子支架的检查.

主要成果:

  • 开发不同类别的非传统蛋白质结合剂.
  • 鉴定抗体衍生和非抗体基的分子支架.
  • 在各种科学学科中展示实用性.

结论:

  • 非传统的结合剂解决了传统抗体的局限性.
关键词:
亲和反应剂 亲和反应剂抗体是对抗体的一种.抗体工程是一种抗体工程.其他非免疫球蛋白.脚手架 脚手架是一个脚手架.

更多相关视频

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
11:02

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

7.8K
Extracellular Protein Microarray Technology for High Throughput Detection of Low Affinity Receptor-Ligand Interactions
06:01

Extracellular Protein Microarray Technology for High Throughput Detection of Low Affinity Receptor-Ligand Interactions

Published on: January 7, 2019

7.2K

相关实验视频

Last Updated: Jun 26, 2025

Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms
15:27

Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms

Published on: April 17, 2017

20.8K
Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
11:02

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

7.8K
Extracellular Protein Microarray Technology for High Throughput Detection of Low Affinity Receptor-Ligand Interactions
06:01

Extracellular Protein Microarray Technology for High Throughput Detection of Low Affinity Receptor-Ligand Interactions

Published on: January 7, 2019

7.2K
  • 蛋白质工程和选加速了新型结合剂的开发.
  • 这些替代结合剂显示出显著的前景,特别是在诊断和治疗方面.